Creative Medical Technology Holdings, Inc. (CELZ)
CELZ Stock Price Chart
Explore Creative Medical Technology Holdings, Inc. interactive price chart. Choose custom timeframes to analyze CELZ price movements and trends.
CELZ Company Profile
Discover essential business fundamentals and corporate details for Creative Medical Technology Holdings, Inc. (CELZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
6 Nov 2015
Employees
4.00
CEO
Timothy Warbington
Description
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
CELZ Financial Timeline
Browse a chronological timeline of Creative Medical Technology Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 7 May 2026
Upcoming earnings on 14 Nov 2025
EPS estimate is -$0.63.
Earnings released on 8 Aug 2025
EPS came in at -$0.48 surpassing the estimated -$0.63 by +23.81%.
Earnings released on 9 May 2025
EPS came in at -$0.83 falling short of the estimated -$0.52 by -59.62%, while revenue for the quarter reached $3.00K .
Earnings released on 14 Mar 2025
EPS came in at -$1.12 falling short of the estimated -$0.63 by -77.78%, while revenue for the quarter reached $3.00K .
Earnings released on 8 Nov 2024
EPS came in at -$0.75 surpassing the estimated -$0.85 by +11.76%.
Earnings released on 9 Aug 2024
EPS came in at -$1.11 falling short of the estimated -$0.84 by -32.14%, while revenue for the quarter reached $8.00K .
Earnings released on 10 May 2024
EPS came in at -$0.73 surpassing the estimated -$1.15 by +36.52%.
Earnings released on 22 Mar 2024
EPS came in at -$1.21 falling short of the estimated -$1.13 by -7.08%, while revenue for the quarter reached $3.00K .
Earnings released on 14 Nov 2023
EPS came in at -$1.02 falling short of the estimated -$0.86 by -18.60%, while revenue for the quarter reached $6.00K .
Earnings released on 11 Aug 2023
EPS came in at -$0.78 surpassing the estimated -$0.83 by +6.02%.
Stock split effective on 12 Jun 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 May 2023
EPS came in at -$0.70 surpassing the estimated -$1.00 by +30.00%.
Earnings released on 31 Mar 2023
EPS came in at -$0.53 surpassing the estimated -$0.70 by +24.29%, while revenue for the quarter reached $18.60K , missing expectations by -93.80%.
Earnings released on 10 Nov 2022
EPS came in at -$0.07 surpassing the estimated -$0.13 by +46.15%, while revenue for the quarter reached $55.00K , missing expectations by -50.00%.
Earnings released on 12 Aug 2022
EPS came in at -$0.20 falling short of the estimated -$0.15 by -33.33%, while revenue for the quarter reached $10.00K , missing expectations by -90.00%.
Earnings released on 13 May 2022
EPS came in at -$0.18 falling short of the estimated -$0.14 by -28.57%, while revenue for the quarter reached $15.00K , meeting expectations.
Earnings released on 30 Mar 2022
EPS came in at -$4.16 falling short of the estimated -$0.23 by -1.71K%, while revenue for the quarter reached $67.75K .
Earnings released on 6 Dec 2021
EPS came in at -$7.52 , while revenue for the quarter reached $10.00K .
Stock split effective on 10 Nov 2021
Shares were split 1 : 500 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 16 Aug 2021
EPS came in at -$12.52 , while revenue for the quarter reached $10.00K .
Earnings released on 17 May 2021
EPS came in at $111.83 .
Earnings released on 17 Mar 2021
EPS came in at -$251.26 , while revenue for the quarter reached $17.50K .
Earnings released on 13 Nov 2020
EPS came in at $1.45 , while revenue for the quarter reached $77.00K .
CELZ Stock Performance
Access detailed CELZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.